Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure and encapsulation of carbonic anhydrase within the α-carboxysome.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Molecular basis of the biogenesis of a protein organelle for ethanolamine utilization.

Science advances·2025
Same author

C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression.

Cell death & disease·2023
Same author

Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells.

Cell death & disease·2023
Same author

Galectin-2 in Health and Diseases.

International journal of molecular sciences·2023
Same author

Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.

Biomolecules·2022
Same journal

Advances in m6A Modification in Pregnancy-Related Disorders and Female Reproductive Endocrine Diseases.

Expert reviews in molecular medicine·2026
Same journal

Dysregulation of the urea cycle - potential targets for treatment and diagnosis in prostate cancer.

Expert reviews in molecular medicine·2026
Same journal

RAGE-Mediated Signaling in Gynecological Disorders: Review of Molecular Mechanisms and Therapeutic Perspectives.

Expert reviews in molecular medicine·2026
Same journal

Two Decades of Therapeutic Trials in Supratentorial Intracerebral Hemorrhage: Lessons from Failure and Success.

Expert reviews in molecular medicine·2026
Same journal

Current <i>in vitro</i> myocardial infarction co-culture models and their verification for clinical relevance.

Expert reviews in molecular medicine·2026
Same journal

The Mechanistic Crosstalk between Probiotics, ncRNAs, and Autophagy: Implications for Colorectal Cancer Precision Medicine.

Expert reviews in molecular medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Developing galectin-3-targeted therapeutics in diseases: three distinct galectin-3 segments for targeting

Paulina Sindrewicz-Goral, Oluwatobi Adegbite, Jessie Y Yu

    Expert Reviews in Molecular Medicine
    |June 15, 2026
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jun 16, 2026

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
    11:13

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

    Published on: July 12, 2018